Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ovid Therapeutics Inc.
Age
13–22
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Is male and 13 to 22 years old (inclusive) at the time of informed consent.
Has a diagnosis of FXS with a confirmed FMR1 full mutation (≥200 CGG repeats).
You may not be if
Concomitant disease or condition that are clinically significant and would limit study participation
Clinically significant lab abnormalities or vital signs at the time of screening
History of uncontrollable seizure disorder or seizure episodes within 6 months of screening or change in the anticonvulsant pharmacotherapy in the past 3 months.
Unable or does not have a caregiver able to comply with study requirements.
Enrolled in any clinical trial within the 30 days before screening.
Clareo Health | A Study of OV101 in Individuals With Fragile X Syndrome
